Empagliflozin Reduces Realworld Heart Failure Hospitalization In Type 2 Diabetes | Latest News RSS feed

Empagliflozin Reduces Realworld Heart Failure Hospitalization In Type 2 Diabetes - Latest News

Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD

(RTTNews) - New data presented showed that Jardiance reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and ... by 38 percent ... read more

New study shows Jardiance consistently reduced the risk of CV death in type 2 diabetes patients

New data presented at the American Heart ... disease type. Observed adverse events were consistent with the known safety profile of Jardiance. "Jardiance is the only oral type 2 diabetes medicine show... read more

SGLT-2 inhibitors promising for heart failure prevention, not treatment

“These trials enrolled a minority of patients with known heart failure, and, in those subgroups, the drugs seems to reduce ... events in type 2 diabetes showed the same result (N Engl J Med. 2017 Aug ... read more

Looking for another news?

Research in the news: Diabetes drug reduces risk of heart failure and may prevent it, study shows

For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations ... and risk factors for heart disease were randomized to receive once-daily doses of either the g... read more

Common diabetes drug does not harm bones, study reassures

So, we conducted a real-world ... type 2 diabetes. This class of medicines can improve blood sugar levels and help reduce heart disease risk," he said. Fralick is from the division of pharmacoepidemio... read more

Lilly, Boehringer to test diabetes drug Jardiance in heart failure

The trials should begin within the next 12 months and are planned to enroll people with chronic heart failure both with and without type II diabetes ... demonstrated that Jardiance reduces the risk of ... read more

New Analysis Finds Hope for Reducing Heart Failure

But over the past decade, 2 things have changed, according to authors of a new paper in Diabetes Obesity and Metabolism. The arrival of a new class of type ... involving empagliflozin, which showed re... read more

Study suggests diabetes medication improves heart structure

A study led by St. Michael's Hospital ... that the diabetes medication empagliflozin has important effects that can improve cardiac structure in people with Type 2 diabetes who also have heart disease ... read more

Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for ...

Initial effectiveness results from the real-world ... empagliflozin, compared with placebo, when added to standard of care, in people with type 2 diabetes and established cardiovascular disease. 1,2 “ ... read more

Turns out, diabetes medication can improve heart structure

Led by St. Michael's Hospital researchers, the study was presented at the American Heart Association meeting in Chicago. "Empagliflozin is used to reduce glucose ... how it may prevent heart failure i... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data ... read more

Lilly diabetes drug slashes deaths in patients with heart risk

It really is big news,” said Dr. Bernard Zinman, director of the Diabetes Centre at Mount Sinai Hospital in Toronto ... societies to recommend that Jardiance be used by type 2 diabetics who have a his... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us